The researchers found increased risk of several forms of alopecia among those taking GLP-1 medications
Mariarosaria De Luca,Michele Roberto Modestino,Abdulrahman Alsergani,Michele Gabriele,Domenico Galzerano,Mario Mallardo,Lavinia Saldamarco,Eduardo Bossone,Antonio Cittadini,Cardiac rehabilitation in overweight and obese patients: Challenges, strategies, and the role of emerging anti-obesity therapies, Current Problems in Cardiology, 51, 7, (103328), (2026)
Now theres a new drug on the horizon that may surpass them bothits called retatrutide
In the central nervous system, the action of GLP-1 and GLP-1RAs on its receptors can affect a variety of brain functions including satiety, thermogenesis, influence blood pressure, neurogenesis, neurodegeneration, retinal repair, and change energy homeostasis [16-20]
When using a semaglutide pen, you should know that the absorption rates of injection sites differ somewhat
Given the strong early trial outcomes of 20-25% average weight loss, many believe Lilly will aim for a fast-track or priority review designation